◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › AXGN

Axogen Inc (AXGN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-08-30

Axogen Inc (AXGN) operates in the MEDICAL DEVICES industry and is headquartered in Alachua, United States with about 622 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, AXGN reported $225M in revenue and ($16M) in net income.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.

Interactive charts & full statements → Open the AXGN valuation workbench →

AXGN Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$251M	$225M	$187M	$159M	$139M	$127M	$112M	$107M	$84M	$60M	$41M	$27M	$17M	$11M	$8M	$5M	$0M	$25M	$0M	$0M	$0M
Gross Profit	$187M	$167M	$142M	$122M	$109M	$104M	$91M	$89M	$71M	$51M	$35M	$22M	$13M	$9M	$6M	$2M	$0M	$25M	$0M	$0M	$0M
Gross Margin %	74.6%	74.3%	75.8%	76.6%	78.5%	82.0%	80.8%	83.7%	84.6%	84.6%	84.3%	82.3%	79.5%	77.7%	74.5%	50.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income (EBIT)	($13M)	($8M)	($3M)	($21M)	($30M)	($25M)	($23M)	($31M)	($20M)	($8M)	($8M)	($9M)	($10M)	($10M)	($8M)	($7M)	($2M)	$16M	($1M)	($1M)	$0M
Operating Margin %	-5.1%	-3.5%	-1.8%	-13.5%	-21.4%	-20.0%	-20.6%	-29.4%	-24.4%	-13.2%	-19.8%	-33.9%	-58.3%	-87.6%	-101.4%	-143.7%	-2025.3%	64.0%	-1453.4%	-796.5%	-313.7%
Net Income	($34M)	($16M)	($10M)	($22M)	($29M)	($27M)	($24M)	($29M)	($22M)	($10M)	($14M)	($13M)	($18M)	($15M)	($9M)	($9M)	($1M)	$15M	($1M)	($1M)	$0M
Net Margin %	-13.4%	-7.0%	-5.3%	-13.7%	-20.9%	-21.2%	-21.2%	-27.3%	-26.7%	-17.3%	-35.1%	-48.9%	-105.3%	-133.0%	-122.4%	-190.1%	-1442.2%	60.4%	-1431.3%	-745.8%	-289.9%
EBITDA	($15M)	$0M	$6M	($13M)	($23M)	($21M)	($19M)	($26M)	($20M)	($7M)	($8M)	($9M)	($10M)	($9M)	($7M)	($7M)	($2M)	$16M	($1M)	($1M)	$0M
Earnings Per Share (EPS)	$-0.67	$-0.34	$-0.23	$-0.51	$-0.69	$-0.65	$-0.60	$-0.74	$-0.60	$-0.31	$-0.47	$-0.51	$-1.00	$-1.08	$-0.85	$-2.49	$-0.31	$3.49	$-0.24	$-0.18	$-0.09
Shares Outstanding (M)	53M	46M	44M	43M	42M	41M	40M	39M	37M	33M	31M	26M	18M	13M	11M	4M	4M	4M	4M	4M	4M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AXGN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$70M	$61M	$60M	$60M	$57M	$49M	$49M	$49M
Gross Profit	$51M	$46M	$44M	$46M	$42M	$35M	$38M	$36M
Gross Margin %	72.7%	75.2%	74.1%	76.5%	74.2%	71.9%	76.1%	74.9%
Operating Income (EBIT)	($2M)	($3M)	($10M)	$2M	$2M	($2M)	$2M	$0M
Operating Margin %	-3.1%	-4.6%	-16.3%	3.2%	2.9%	-3.4%	4.1%	-0.7%
Net Income	($2M)	($20M)	($13M)	$1M	$1M	($4M)	$0M	($2M)
Net Margin %	-2.2%	-31.9%	-22.0%	1.2%	1.0%	-7.9%	0.9%	-3.8%
EBITDA	($2M)	($17M)	($8M)	$13M	$4M	$0M	$4M	$2M
Earnings Per Share (EPS)	$-0.03	$-0.38	$-0.28	$0.02	$0.01	$-0.08	$0.01	$-0.04
Shares Outstanding (M)	53M	52M	47M	46M	46M	45M	48M	44M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AXGN Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$9M	$1M	$5M	($6M)	($16M)	($13M)	($10M)	($20M)	($18M)	($9M)	($11M)	($13M)	($10M)	($10M)	($9M)	($7M)	($2M)	$15M	$0M	$0M	$0M
Capital Expenditures (CapEx)	$7M	$4M	$5M	$15M	$21M	$28M	$23M	$5M	$7M	$1M	$1M	$1M	$1M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	$3M	($3M)	$0M	($21M)	($37M)	($42M)	($32M)	($25M)	($24M)	($11M)	($12M)	($14M)	($11M)	($11M)	($9M)	($7M)	($2M)	$15M	($1M)	$0M	$0M
FCF Margin %	1.0%	-1.3%	0.0%	-13.0%	-26.9%	-32.8%	-28.7%	-23.5%	-29.1%	-17.4%	-30.1%	-49.8%	-65.7%	-97.6%	-114.3%	-147.8%	-2706.6%	62.0%	-687.8%	-464.9%	-22.7%
Dividends Paid	—	—	—	—	—	—	$1M	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$4M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AXGN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$1M	$2M	$3M	$3M	$8M	($13M)	$9M	$4M
Capital Expenditures (CapEx)	$1M	$3M	$1M	$2M	$1M	$0M	$1M	$1M
Free Cash Flow (FCF)	$1M	($1M)	$2M	$1M	$7M	($13M)	$8M	$3M
FCF Margin %	0.9%	-2.0%	3.0%	2.3%	12.4%	-27.7%	16.0%	5.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AXGN Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$305M	$222M	$204M	$197M	$195M	$208M	$201M	$155M	$160M	$59M	$46M	$38M	$16M	$28M	$20M	$12M	$10M	$17M	$1M	$1M	$2M
Cash & Cash Equivalents	$95M	$36M	$28M	$31M	$15M	$33M	$49M	$36M	$24M	$37M	$30M	$26M	$8M	$20M	$14M	$8M	$7M	$16M	$0M	$1M	$1M
Total Liabilities	$49M	$93M	$100M	$101M	$94M	$95M	$78M	$22M	$13M	$34M	$31M	$29M	$28M	$28M	$23M	$6M	$0M	$6M	$0M	$0M	$0M
Total Debt (Short + Long-Term)	$2M	$51M	$49M	$48M	$67M	$67M	$55M	$3M	$0M	$27M	$24M	$50M	$50M	$27M	$43M	$5M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$256M	$129M	$104M	$96M	$101M	$113M	$123M	$132M	$147M	$25M	$15M	$8M	($11M)	$0M	($3M)	$6M	$10M	$11M	$0M	$1M	$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AXGN viewer.

Other Companies in MEDICAL DEVICES

LIVN · LivaNova PLC — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion
TMDX · TransMedics Group Inc — $3 billion
NEOG · Neogen Corporation — $3 billion
ALMR · Alamar Biosciences, Inc. Common Stock — $2 billion
INSP · Inspire Medical Systems Inc — $2 billion
UFPT · UFP Technologies Inc — $2 billion
BFLY · Butterfly Network Inc — $2 billion

← AXG All “A” companies AXIN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.